Cisplatin induces resistance by triggering differentiation of testicular embryonal carcinoma cells

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Abada, Paolo B ^a,b   Howell, Stephen B ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CISPLATIN; FIBRONECTIN; MESSENGER RNA; NESTIN; OCTAMER TRANSCRIPTION FACTOR 4; PACLITAXEL; RETINOIC ACID; SCG10 PROTEIN; TRANSCRIPTION FACTOR NANOG; UNCLASSIFIED DRUG;

ARTICLE; CANCER RESISTANCE; CELL DIFFERENTIATION; CERVICAL CANCER CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; EMBRYONAL CARCINOMA CELL LINE; GENE EXPRESSION; GERM CELL TUMOR; HUMAN; HUMAN CELL; PROSTATE CANCER CELL LINE;

BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL SURVIVAL; CISPLATIN; DRUG RESISTANCE, NEOPLASM; FIBRONECTINS; HOMEODOMAIN PROTEINS; HUMANS; MALE; MEMBRANE PROTEINS; NEOPLASMS, GERM CELL AND EMBRYONAL; NESTIN; OCTAMER TRANSCRIPTION FACTOR-3; REAL-TIME POLYMERASE CHAIN REACTION; TESTICULAR NEOPLASMS; TRETINOIN;

EID: 84900339167     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087444     Document Type: Article

References (51)

1. Looijenga LH, Gillis AJ, Stoop H, Biermann K, Oosterhuis JW (2011) Dissecting the molecular pathways of (testicular) germ cell tumour pathogenesis; from initiation to treatment-resistance. Int J Androl 34: e234-251.
2. di Pietro A, Vries EG, Gietema JA, Spierings DC, de Jong S (2005) Testicular germ cell tumours: the paradigm of chemo-sensitive solid tumours. Int J Biochem Cell Biol 37: 2437-2456. (Pubitemid 41400315)
3. Horwich A, Shipley J, Huddart R (2006) Testicular germ-cell cancer. Lancet 367: 754-765. (Pubitemid 43326294)
4. Masters JR, Koberle B (2003) Curing metastatic cancer: lessons from testicular germ-cell tumours. Nat Rev Cancer 3: 517-525. (Pubitemid 37328839)
5. Mayer F, Stoop H, Scheffer GL, Scheper R, Oosterhuis JW, et al. (2003) Molecular determinants of treatment response in human germ cell tumors. Clin Cancer Res 9: 767-773. (Pubitemid 36182613)
6. Gagliardi AR, Wright FC, Grunfeld E, Davis D (2008) Colorectal cancer care knowledge mapping: identifying priorities for knowledge translation research. Cancer Causes Control 19: 615-630.
7. Rocha CR, Lerner LK, Okamoto OK, Marchetto MC, Menck CF (2013) The role of DNA repair in the pluripotency and differentiation of human stem cells. Mutation Research 72: 25-35.
8. Simonatto M, Latella L, Puri PL (2007) DNA damage and cellular differentiation: more questions than responses. J Cell Physiol 213: 642-648. (Pubitemid 350058256)
9. Duale N, Lindeman B, Komada M, Olsen AK, Andreassen A, et al. (2007) Molecular portrait of cisplatin induced response in human testis cancer cell lines based on gene expression profiles. Mol Cancer 6: 53.
10. Andrews PW (1988) Human teratocarcinomas. Biochim Biophys Acta 948: 17-36.
11. Disaia PJ, Sinkovics JG, Rutledge FN, Smith JP (1972) Cell-mediated immunity to human malignant cells. Am J Obstet Gynecol 114: 979-989.
12. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW (1979) Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 17: 16-23. (Pubitemid 9239413)
13. Stone KR, Mickey DD, Wunderli H, Mickey GH, Paulson DF (1978) Isolation of a human prostate carcinoma cell line (DU 145). Int J Cancer 21: 274-281. (Pubitemid 8283045)
14. Pera MF, Cooper S, Mills J, Parrington JM (1989) Isolation and characterization of a multipotent clone of human embryonal carcinoma cells. Differentiation 42: 10-23. (Pubitemid 20011161)
15. Hogan B, Fellous M, Avner P, Jacob F (1977) Isolation of a human teratoma cell line which expresses F9 antigen. Nature 270: 515-518.
16. Akagi T, Sasai K, Hanafusa H (2003) Refractory nature of normal human diploid fibroblasts with respect to oncogene-mediated transformation. Proc Natl Acad Sci U S A 100: 13567-13572. (Pubitemid 37444782)
17. Kelland LR, Mistry P, Abel G, Freidlos F, Loh SY, et al. (1992) Establishment and characterization of an in vitro model of acquired resistance to cisplatin in a human testicular nonseminomatous germ cell line. Cancer Res 52: 1710-1716.
18. Malanchi I, Santamaria-Martinez A, Susanto E, Peng H, Lehr HA, et al. (2012) Interactions between cancer stem cells and their niche govern metastatic colonization. Nature 481: 85-89.
19. Katoh M (2002) Regulation of WNT signaling molecules by retinoic acid during neuronal differentiation in NT2 cells: threshold model of WNT action (review). Int J Mol Med 10: 683-687.
20. Timmer-Bosscha H, de Vries EG, Meijer C, Oosterhuis JW, Mulder NH (1998) Differential effects of all-trans-retinoic acid, docosahexaenoic acid, and hexadecylphosphocholine on cisplatin-induced cytotoxicity and apoptosis in a cisplantin-sensitive and resistant human embryonal carcinoma cell line. Cancer Chemother Pharmacol 41: 469-476. (Pubitemid 28140711)
21. Skotheim RI, Lind GE, Monni O, Nesland JM, Abeler VM, et al. (2005) Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development. Cancer Res 65: 5588-5598. (Pubitemid 40911159)
22. Houldsworth J, Reuter VE, Bosl GJ, Chaganti RS (2001) ID gene expression varies with lineage during differentiation of pluripotential male germ cell tumor cell lines. Cell Tissue Res 303: 371-379. (Pubitemid 32250109)
23. Chadalavada RS, Houldsworth J, Olshen AB, Bosl GJ, Studer L, et al. (2005) Transcriptional program of bone morphogenetic protein-2-induced epithelial and smooth muscle differentiation of pluripotent human embryonal carcinoma cells. Funct Integr Genomics 5: 59-69. (Pubitemid 40425087)
24. Choi SC, Choi JH, Park CY, Ahn CM, Hong SJ, et al. (2012) Nanog regulates molecules involved in stemness and cell cycle-signaling pathway for maintenance of pluripotency of P19 embryonal carcinoma stem cells. J Cell Physiol 227: 3678-3692.
25. Nettersheim D, Biermann K, Gillis AJ, Steger K, Looijenga LH, et al. (2011) NANOG promoter methylation and expression correlation during normal and malignant human germ cell development. Epigenetics 6: 114-122.
26. Kashyap V, Rezende NC, Scotland KB, Shaffer SM, Persson JL, et al. (2009) Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs. Stem Cells Dev 18: 1093-1108.
27. Werner S, Frey S, Riethdorf S, Schulze C, Alawi M, et al. (2013) Dual Roles of the Transcription Factor Grainyhead-like 2 (GRHL2) in Breast Cancer. J Biol Chem.
28. Moreno-Bueno G, Salvador F, Martin A, Floristan A, Cuevas EP, et al. (2011) Lysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomas. EMBO Mol Med 3: 528-544.
29. Musch T, Oz Y, Lyko F, Breiling A (2010) Nucleoside drugs induce cellular differentiation by caspase-dependent degradation of stem cell factors. PLoS One 5: e10726.
30. Fujita J, Crane AM, Souza MK, Dejosez M, Kyba M, et al. (2008) Caspase activity mediates the differentiation of embryonic stem cells. Cell Stem Cell 2: 595-601. (Pubitemid 351729216)
31. Curtin JC, Dragnev KH, Sekula D, Christie AJ, Dmitrovsky E, et al. (2001) Retinoic acid activates p53 in human embryonal carcinoma through retinoid receptor-dependent stimulation of p53 transactivation function. Oncogene 20: 2559-2569. (Pubitemid 32531353)
32. Lin T, Chao C, Saito S, Mazur SJ, Murphy ME, et al. (2005) p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol 7: 165-171. (Pubitemid 40268131)
33. Mueller T, Mueller LP, Luetzkendorf J, Voigt W, Simon H, et al. (2006) Loss of Oct-3/4 expression in embryonal carcinoma cells is associated with induction of cisplatin resistance. Tumour Biol 27: 71-83.
34. Chen T, Du J, Lu G (2012) Cell growth arrest and apoptosis induced by Oct4 or Nanog knockdown in mouse embryonic stem cells: a possible role of Trp53. Mol Biol Rep 39: 1855-1861.
35. Przyborski SA, Christie VB, Hayman MW, Stewart R, Horrocks GM (2004) Human embryonal carcinoma stem cells: models of embryonic development in humans. Stem Cells Dev 13: 400-408. (Pubitemid 39223291)
36. Wu C, Alman BA (2008) Side population cells in human cancers. Cancer Lett 268: 1-9.
37. Shah AN, Summy JM, Zhang J, Park SI, Parikh NU, et al. (2007) Development and characterization of gemcitabine-resistant pancreatic tumor cells. Ann Surg Oncol 14: 3629-3637. (Pubitemid 350160137)
38. Dylla SJ, Beviglia L, Park IK, Chartier C, Raval J, et al. (2008) Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy. PLoS One 3: e2428.
39. Perona R, Lopez-Ayllon BD, de Castro Carpeno J, Belda-Iniesta C (2011) A role for cancer stem cells in drug resistance and metastasis in non-small-cell lung cancer. Clin Transl Oncol 13: 289-293.
40. Lee M, Nam EJ, Kim SW, Kim S, Kim JH, et al. (2012) Prognostic impact of the cancer stem cell-related marker NANOG in ovarian serous carcinoma. Int J Gynecol Cancer 22: 1489-1496.
41. Izumiya M, Kabashima A, Higuchi H, Igarashi T, Sakai G, et al. (2012) Chemoresistance is associated with cancer stem cell-like properties and epithelial-to-mesenchymal transition in pancreatic cancer cells. Anticancer Res 32: 3847-3853.
42. Bourguignon LY, Earle C, Wong G, Spevak CC, Krueger K (2012) Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells. Oncogene 31: 149-160.
43. Gutekunst M, Oren M, Weilbacher A, Dengler MA, Markwardt C, et al. (2011) p53 hypersensitivity is the predominant mechanism of the unique responsiveness of testicular germ cell tumor (TGCT) cells to cisplatin. PLoS One 6: e19198.
44. Gutekunst M, Mueller T, Weilbacher A, Dengler MA, Bedke J, et al. (2013) Cisplatin hypersensitivity of testicular germ cell tumors is determined by high constitutive Noxa levels mediated by Oct4. Cancer Res. 73:1460-1469.
45. Wang TH, Wang HS, Soong YK (2000) Paclitaxel-induced cell death: where the cell cycle and apoptosis come together. Cancer 88: 2619-2628.
46. Siddik ZH (2003) Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22: 7265-7279. (Pubitemid 37487159)
47. Brozovic A, Osmak M (2007) Activation of mitogen-activated protein kinases by cisplatin and their role in cisplatin-resistance. Cancer Lett 251: 1-16. (Pubitemid 46589761)
48. Binetruy B, Heasley L, Bost F, Caron L, Aouadi M (2007) Concise review: regulation of embryonic stem cell lineage commitment by mitogen-activated protein kinases. Stem Cells 25: 1090-1095. (Pubitemid 46684867)
49. Varma S, Cao Y, Tagne JB, Lakshminarayanan M, Li J, et al. (2012) The transcription factors Grainyhead-like 2 and NK2-homeobox 1 form a regulatory loop that coordinates lung epithelial cell morphogenesis and differentiation. J Biol Chem 287: 37282-37295.
50. Xiang X, Deng Z, Zhuang X, Ju S, Mu J, et al. (2012) Grhl2 determines the epithelial phenotype of breast cancers and promotes tumor progression. PLoS One 7: e50781.
51. Tsai JH, Donaher JL, Murphy DA, Chau S, Yang J (2012) Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell 22: 725-736.